Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeomin in Bruxism
NCT05980559Phase 3Not yet recruiting
- Sponsor
- Alexandria University
- Start
- Jan 2024
- Primary completion
- Jan 2024
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of botulinum toxin type A in bruxism, sponsored by Alexandria University. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
bruxism
Beyond the preview
Go deeper on NCT05980559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05980559.